|
Rhonda B. Friedman is President and COO of Coagulation Diagnostics; Inc. Dr. Friedman previously worked with the MEDSTAT Group in Washington, D.C. During her tenure at the MEDSTAT Group, she served as Director, Clinical Research and Outcomes from 1987 to 1995; she served as Acting Vice President and General Manager of MEDSTAT’s Research and Policy Division from 1994 to 1995; and from 1995 to 1997 she served as Vice President, Disease Management. Dr. Friedman has a wide range of experience in global clinical trials, outcomes research, strategic business planning, business development, and financial and personnel management.
Dr. Friedman earned her BA from Hobart and William Smith Colleges in 1971. She has also earned an ScM and ScD in 1974 and 1978, respectively, both from the Johns Hopkins University School of Hygiene and Public Health. | 